DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Hellmann MD, Ciuleanu TE, Pluzanski A. et al.
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.
N Engl J Med 2018;
378: 2093-2104
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.